Xiromed`s Generic Guanfacine Hydrochloride Receives Approval in the U.S.
Health Canada Issues Recall of JAMP Guanfacine XR 1 mg: Foreign tablets
Alembic's Generic Guanfacine Hydrochloride Receives Approval in US
TWI Pharms`s Generic Guanfacine Hydrochloride Receives Approval in the US
WESTON, Fla., March 31, 2021 /PRNewswire/ - Apotex Corp is voluntarily recalling three (3) lots of Guanfacine Extended-Release Tablets 2mg to the consumer level due to trace amounts of Quetiapine Fumarate in one lot RX1663. Out of an abundance of caution, lots RX1662 and RX1664 are also included in the scope of this voluntary recall, as they were manufactured in the same campaign as lot RX1663.
Unichem Labs Generic Guanfacine Hydrochloride Receives Approval in US
Yichang Humanwell`s Generic Guanfacine Receives Approval in US
Shire’s partner, Shionogi, filed application to expand INTUNIV indication in Japan to include adults with ADHD.
Apotex's Generic Guanfacine Hydrochloride Receives Approval in US
Sun Pharm’s Generic Guanfacine Hydrochloride Receives Approval In US